- Home
- COGT vs ASPI Comparison
COGT vs ASPI Comparison
Compare COGT & ASPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COGT
- ASPI
- Stock Information
- Founded
- COGT 2014
- ASPI 2021
- Country
- COGT United States
- ASPI United States
- Employees
- COGT N/A
- ASPI N/A
- Industry
- COGT Biotechnology: Pharmaceutical Preparations
- ASPI Major Chemicals
- Sector
- COGT Health Care
- ASPI Industrials
- Exchange
- COGT Nasdaq
- ASPI Nasdaq
- Market Cap
- COGT 555.6M
- ASPI 470.6M
- IPO Year
- COGT 2018
- ASPI 2022
- Fundamental
- Price
- COGT $5.73
- ASPI $7.38
- Analyst Decision
- COGT Buy
- ASPI Strong Buy
- Analyst Count
- COGT 6
- ASPI 2
- Target Price
- COGT $15.20
- ASPI $7.75
- AVG Volume (30 Days)
- COGT 1.2M
- ASPI 4.0M
- Earning Date
- COGT 05-06-2025
- ASPI 05-20-2025
- Dividend Yield
- COGT N/A
- ASPI N/A
- EPS Growth
- COGT N/A
- ASPI N/A
- EPS
- COGT N/A
- ASPI N/A
- Revenue
- COGT N/A
- ASPI $4,405,477.00
- Revenue This Year
- COGT N/A
- ASPI $690.06
- Revenue Next Year
- COGT N/A
- ASPI $93.09
- P/E Ratio
- COGT N/A
- ASPI N/A
- Revenue Growth
- COGT N/A
- ASPI 245.97
- 52 Week Low
- COGT $3.72
- ASPI $1.86
- 52 Week High
- COGT $12.61
- ASPI $9.33
- Technical
- Relative Strength Index (RSI)
- COGT 60.43
- ASPI 57.20
- Support Level
- COGT $4.80
- ASPI $5.97
- Resistance Level
- COGT $4.99
- ASPI $9.10
- Average True Range (ATR)
- COGT 0.34
- ASPI 0.74
- MACD
- COGT 0.10
- ASPI -0.01
- Stochastic Oscillator
- COGT 75.81
- ASPI 45.05
About COGT Cogent Biosciences Inc.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
About ASPI ASP Isotopes Inc.
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. The company utilizes technology developed in South Africa over the past 20 years to enrich isotopes of elements or molecules with low atomic masses.